ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 80 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,436 | -55.9% | 647,652 | -33.2% | 0.01% | -42.9% |
Q2 2023 | $10,054 | -0.8% | 969,552 | -22.6% | 0.01% | +7.7% |
Q1 2023 | $10,130 | -42.7% | 1,252,152 | +11.6% | 0.01% | -45.8% |
Q4 2022 | $17,668 | -99.9% | 1,121,752 | -5.4% | 0.02% | -7.7% |
Q3 2022 | $18,655,000 | +0.5% | 1,185,178 | -10.9% | 0.03% | +18.2% |
Q2 2022 | $18,562,000 | -26.1% | 1,329,678 | -8.8% | 0.02% | -24.1% |
Q1 2022 | $25,129,000 | +3.1% | 1,457,578 | -13.1% | 0.03% | -3.3% |
Q4 2021 | $24,382,000 | -33.0% | 1,676,878 | -17.0% | 0.03% | -36.2% |
Q3 2021 | $36,376,000 | -14.8% | 2,020,878 | -16.9% | 0.05% | -11.3% |
Q2 2021 | $42,704,000 | -43.3% | 2,431,878 | -18.6% | 0.05% | -43.6% |
Q1 2021 | $75,259,000 | +255.9% | 2,986,478 | -8.6% | 0.09% | +308.7% |
Q4 2020 | $21,145,000 | +139.6% | 3,268,178 | -4.8% | 0.02% | +155.6% |
Q3 2020 | $8,824,000 | +66.1% | 3,433,390 | +4.7% | 0.01% | +80.0% |
Q2 2020 | $5,313,000 | +60.9% | 3,279,840 | +3.3% | 0.01% | +66.7% |
Q1 2020 | $3,303,000 | -37.2% | 3,175,636 | +14.1% | 0.00% | -25.0% |
Q4 2019 | $5,259,000 | +147.4% | 2,782,297 | +41.3% | 0.00% | +100.0% |
Q3 2019 | $2,126,000 | +38.8% | 1,968,716 | +181.4% | 0.00% | +100.0% |
Q2 2019 | $1,532,000 | -40.2% | 699,580 | +63.7% | 0.00% | -50.0% |
Q1 2019 | $2,560,000 | +262.1% | 427,380 | +346.7% | 0.00% | +100.0% |
Q4 2018 | $707,000 | -9.8% | 95,680 | +231.1% | 0.00% | 0.0% |
Q2 2017 | $784,000 | -70.2% | 28,900 | -67.2% | 0.00% | -75.0% |
Q1 2017 | $2,627,000 | -44.6% | 88,079 | -49.6% | 0.00% | -42.9% |
Q4 2016 | $4,739,000 | – | 174,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |